The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Inflammation in Atrial Fibrillation
Open accessAbstract
Atrial fibrillation (AF) is associated with increased risk for stroke and systemic embolism. There is plausible evidence linking inflammation to the initiation and perpetuation of AF and AF-related thrombosis. Various inflammatory markers (C-reactive protein, tumor necrosis factor-α, interleukin-2, interleukin-6, and interleukin-8) have been associated with AF. Proposed mechanisms linking inflammation and the prothrombotic AF state include endothelial activation/damage, production of tissue factor from monocytes, increased platelet activation, and increased expression of fibrinogen. The present review aims to provide an update on the association of inflammation and AF, including the impact of inflammatory markers on clinical presentation and outcome of AF patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Update on the Association of Inflammation and Atrial Fibrillation
PATEL, P., DOKAINISH, H., TSAI, P., & LAKKIS, N. (2010) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2010.01774.x · Cited by 190
Research works printed but not linked: 45
- Watson, 2009, Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited, Lancet, 373, 155, 10.1016/S0140-6736(09)60040-4 · DOI · Paper page
- Friedrichs, 2011, Inflammatory pathways underlying atrial fibrillation, Trend Molec Med, 17, 556, 10.1016/j.molmed.2011.05.007 · DOI
- Devaraj, 2009, The evolving role of C-reactive protein in atherothrombosis, Clin Chem, 55, 229, 10.1373/clinchem.2008.108886 · DOI · Paper page
- Rizos, 2010, Hypertension and paroxysmal atrial fibrillation: a novel predictive role of high sensitivity C-reactive protein in cardioversion and long-term recurrence, J Hum Hypertens, 24, 447, 10.1038/jhh.2009.89 · DOI
- Marott, 2010, Does elevated C-reactive protein increase atrial fibrillation risk?, J Am Coll Cardiol, 56, 789, 10.1016/j.jacc.2010.02.066 · DOI
- Ederhy, 2012, C-reactive protein and transesophageal echocardiographic markers of thromboembolism in patients with atrial fibrillation, Int J Cardiol, 159, 40, 10.1016/j.ijcard.2011.02.020 · DOI
- Qu, 2009, Activated nuclear factor-kappaβ and increased tumor necrosis factor-alpha in atrial tissue of atrial fibrillation, Scand Cardiovasc J, 43, 292, 10.1080/14017430802651803 · DOI
- Deng, 2011, Role of tumor necrosis factor-alpha in the pathogenesis of atrial fibrillation, Chin Med J, 124, 1976
- Li, 2010, Role of inflammation and oxidative stress in atrial fibrillation, Heart Rhythm, 7, 438, 10.1016/j.hrthm.2009.12.009 · DOI · Paper page
- Pinto, 2009, Immuno-inflammatory predictors of stroke at follow-up in patients with chronic non-valvular atrial fibrillation (NVAF), Clin Sci (Lond), 116, 781, 10.1042/CS20080372 · DOI
- Olejniczak, 2008, Biological properties of interleukin 2 and its role in pathogenesis of selected diseases—a review, Med Sci Monit, 14, RA179
- Hak, 2009, Interleukin-2 as a predictor of early postoperative atrial fibrillation after cardiopulmonary bypass graft (CABG), J Interferon Cytokine Res, 29, 327, 10.1089/jir.2008.0082.2906 · DOI
- Kourliouros, 2009, Current concepts in the pathogenesis of atrial fibrillation, Am Heart J, 157, 243, 10.1016/j.ahj.2008.10.009 · DOI
- Marcus, 2008, Interleukin-6 and atrial fibrillation in patients with coronary artery disease: data from the Heart and Soul Study, Am Heart J, 155, 303, 10.1016/j.ahj.2007.09.006 · DOI · Paper page
- Leftheriotis, 2009, The predictive value of inflammatory and oxidative markers following the successful cardioversion of persistent lone atrial fibrillation, Int J Cardiol, 135, 361, 10.1016/j.ijcard.2008.04.012 · DOI
- Burzotta, 2010, Characterisation and validity of inflammatory biomarkers in the prediction of post-operative atrial fibrillation in coronary artery disease patients, Thromb Haemost, 104, 122, 10.1160/TH09-12-0837 · DOI
- Conway, 2009, Prognostic impact of hs-CRP and IL-6 in patients with persistent atrial fibrillation treated with electrical cardioversion, Scand J Clin Lab Invest, 69, 425, 10.1080/00365510802676848 · DOI
- Henningsen, 2009, Prognostic impact of hs-CRP and IL-6 in patients undergoing radiofrequency catheter ablation for atrial fibrillation, Scand Cardiovasc J, 43, 285, 10.1080/14017430802653676 · DOI
- Melenovsky, 2008, Interleukin-8 and atrial fibrillation, Europace, 10, 784, 10.1093/europace/eun154 · DOI
- Liuba, 2008, Source of inflammatory markers in patients with atrial fibrillation, Europace, 10, 848, 10.1093/europace/eun111 · DOI
- De Gennaro, 2012, Inflammatory activation and carbohydrate antigen-125 levels in subjects with atrial fibrillation, Eur J Clin Invest, 42, 371, 10.1111/j.1365-2362.2011.02592.x · DOI
- Schnabel, 2009, Relation of multiple inflammatory biomarkers to incident atrial fibrillation, Am J Cardiol, 104, 92, 10.1016/j.amjcard.2009.02.053 · DOI
- Pellegrino, 2011, Inflammatory activation in an unselected population of subjects with atrial fibrillation: links with structural heart disease, atrial remodeling and recent onset, Intern Emerg Med
- Marcus, 2010, Intracardiac and extracardiac markers of inflammation during atrial fibrillation, Heart Rhythm, 7, 149, 10.1016/j.hrthm.2009.10.004 · DOI · Paper page
- Conen, 2010, A multimarker approach to assess the influence of inflammation on the incidence of atrial fibrillation in women, Eur Heart J, 31, 1730, 10.1093/eurheartj/ehq146 · DOI
- Marcus, 2008, Markers of inflammation before and after curative ablation of atrial flutter, Heart Rhythm, 5, 215, 10.1016/j.hrthm.2007.10.007 · DOI
- Kallergis, 2008, The role of the post-cardioversion time course of hs-CRP levels in clarifying the relationship between inflammation and persistence of atrial fibrillation, Heart, 94, 200, 10.1136/hrt.2006.108688 · DOI
- Akar, 2008, Acute onset human atrial fibrillation is associated with local cardiac platelet activation and endothelial dysfunction, J Am Coll Cardiol, 51, 1790, 10.1016/j.jacc.2007.11.083 · DOI
- Kaski, 2011, Inflammation and thrombosis in atrial fibrillation, Rev Esp Cardiol, 64, 551, 10.1016/j.recesp.2011.03.015 · doi:10.1016/j.recesp.2011.03.015
- Tousoulis, 2009, Oxidative stress and inflammatory process in patients with atrial fibrillation: the role of left atrium distension, Int J Cardiol, 136, 258, 10.1016/j.ijcard.2008.04.087 · DOI
- Raviele, 2011, Endothelial dysfunction and atrial fibrillation: what is the relationship?, J Cardiovasc Electrophysiol, 22, 383, 10.1111/j.1540-8167.2010.01954.x · doi:10.1111/j.1540-8167.2010.01954.x
- Yacoub, 2010, Enhanced levels of soluble cd40 ligand exacerbate platelet aggregation and thrombus formation through a cd40-dependent tumor necrosis factor receptor-associated factor-2/rac1/p38 mitogen-activated protein kinase signaling pathway, Arterioscler Thromb Vasc Biol, 30, 2424, 10.1161/ATVBAHA.110.216143 · DOI
- Shantsila, 2009, The role of monocytes in thrombotic disorders, Thromb Haemost, 102, 916, 10.1160/TH09-01-0023 · DOI
- Choudhury, 2008, Soluble cd40 ligand, platelet surface cd40 ligand, and total platelet cd40 ligand in atrial fibrillation: relationship to soluble p-selectin, stroke risk factors, and risk factor intervention, Chest, 134, 574, 10.1378/chest.07-2745 · DOI
- Pamukcu, 2011, The CD40-CD40L system in cardiovascular disease, Ann Med, 43, 331, 10.3109/07853890.2010.546362 · DOI
- Cunnington, 2009, Preoperative scd40l levels predict risk of atrial fibrillation after off-pump coronary artery bypass graft surgery, Circulation, 120, 170
- Duygu, 2008, Prognostic value of plasma soluble cd40 ligand in patients with chronic non-valvular atrial fibrillation, Europace, 10, 210, 10.1093/europace/eum284 · DOI
- Hayashi, 2011, Platelet activation and induction of tissue factor in acute and chronic atrial fibrillation: involvement of mononuclear cell-platelet interaction, Thrombosis Research, 128, e113, 10.1016/j.thromres.2011.07.013 · DOI
- Almroth, 2009, Atorvastatin and persistent atrial fibrillation after cardioversion: a randomized placebo controlled multicentre study, Eur Heart J, 30, 827, 10.1093/eurheartj/ehp006 · DOI
- Ohara, 2008, Accumulation of risk factors enhances the prothrombotic state in atrial fibrillation, Int J Cardiol, 126, 316, 10.1016/j.ijcard.2007.06.020 · DOI
- Roldán, 2011, Plasma von Willebrand factor levels are an independent risk factor for adverse events including mortality and major bleeding in anticoagulated atrial fibrillation patients, J Am Coll Cardiol, 57, 2496, 10.1016/j.jacc.2010.12.033 · DOI
- Marín, 2004, Factor XIII Val34Leu polymorphism modulates the prothrombotic and inflammatory state associated with atrial fibrillation, J Mol Cell Cardiol, 37, 699, 10.1016/j.yjmcc.2004.06.001 · DOI
- Barber, 2004, Dementia in subjects with atrial fibrillation: hemostatic function and the role of anticoagulation, J Thromb Haemost, 2, 1873, 10.1111/j.1538-7836.2004.00993.x · DOI
- Heeringa, 2006, A longitudinal population-based study of prothrombotic factors in elderly subjects with atrial fibrillation: the Rotterdam Study 1990-1999, J Thromb Haemost, 4, 1944, 10.1111/j.1538-7836.2006.02115.x · DOI
- Choudhury, 2007, Platelet surface CD62P and CD63, mean platelet volume, and soluble/platelet P-selectin as indexes of platelet function in atrial fibrillation: a comparison of “healthy control subjects” and “disease control subjects” in sinus rhythm, J Am Coll Cardiol, 49, 1957, 10.1016/j.jacc.2007.02.038 · DOI
Cited by
Temporal relationship between subclinical atrial fibrillation and embolic events
Brambatti, M., Connolly, S. J., Gold, M. R., Morillo, C. A., Capucci, A., Muto, C., Lau, C. P., Van Gelder, I. C., Hohnloser, S. H., Carlson, M., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.007825 · Cited by 676
Bennett, J. M., Reeves, G., Billman, G. E., & Sturmberg, J. P. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00316 · Cited by 531
Systemic inflammation and arrhythmic risk: lessons from rheumatoid arthritis
Lazzerini, P. E., Capecchi, P. L., & Laghi-Pasini, F. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw208 · Cited by 299
Soliman, E. Z., Lopez, F., O’Neal, W. T., Chen, L. Y., Bengtson, L., Zhang, Z.-M., Loehr, L., Cushman, M., & Alonso, A. (2015) · Circulation · doi:10.1161/circulationaha.114.014145 · Cited by 174
Fatemi, O., Yuriditsky, E., Tsioufis, C., Tsachris, D., Morgan, T., Basile, J., Bigger, T., Cushman, W., Goff, D., Soliman, E. Z., et al. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.07.045 · Cited by 173
Metadata
- Authors
- Guo, Y., Lip, G. Y. H., & Apostolakis, S.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2012-12
- Volume
- 60
- Issue
- 22
- Pages
- 2263-2270
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W1971347950
- Cited by
- 863
- References
- 1
- FWCI
- 25.32
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 368 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Inflammation in Atrial Fibrillation. https://app.cochat.ai/papers/10.1016/j.jacc.2012.04.063
- The paper
- Guo, Y., Lip, G. Y. H., & Apostolakis, S. (2012). Inflammation in Atrial Fibrillation. Journal of the American College of Cardiology. https://doi.org/10.1016/j.jacc.2012.04.063
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.